Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma, Malignant × dostarlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Endometrial Neoplasms 10 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Breast Neoplasms 3 Rectal Neoplasms 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer (LARC) 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Neuroendocrine 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1

Interventions

Cisplatin 26 Pemetrexed 22 pembrolizumab 11 Nivolumab 9 Carboplatin 8 durvalumab 6 atezolizumab 6 Gemcitabine 6 sodium thiosulfate 5 Radiotherapy, Intensity-Modulated 5 Drug Therapy 5 Cyclophosphamide 5 tremelimumab 4 Radiotherapy 4 sargramostim 3 Vinorelbine 3 Photochemotherapy 3 Ipilimumab 3 Doxorubicin 3 Dihematoporphyrin Ether 3 Chemotherapy, Adjuvant 3 Cerebral Decortication 3 vatalanib 2 regorafenib 2 niraparib 2 lenvatinib 2 cemiplimab 2 avelumab 2 aldesleukin 2 Trioxsalen 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡